Leu-Valorphin-Arg CAS NO.135861-77-7

Leu-Valorphin-Arg CAS NO.135861-77-7

Leu-Valorphin-Arg CAS NO.135861-77-7

Leu-Valorphin-Arg CAS NO.135861-77-7

Leu-Valorphin-Arg CAS NO.135861-77-7

Leu-Valorphin-Arg (CAS NO. 135861-77-7) is a synthetic tetrapeptide with the sequence Leu-Val-Val-Tyr-Arg-NH2 (based on standard nomenclature where "Leu-Valorphin" implies a core structure extended with an Arg residue). It is a modified analog derived from the valorphin/hemorphin family of peptides, which are bioactive fragments originating from hemoglobin. This research-grade compound is designed for studying opioid and non-opioid peptide signaling, particularly in relation to cardiovascular and neurological functions.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Leu-Valorphin-Arg
CAS NO.
135861-77-7
Appearance
White to off-white lyophilized powder
Molecular Formula
C56H84N14O13
Molecular Weight
1161.38/mol 
Purity (RP-HPLC)
≥98%
Solubility

Soluble in water (≥20 mg/mL), dilute acetic acid, or DMSO

Endotoxin≤1.0 EU/mg
Biological Activity
Opioid receptor agonist (high affinity for μ-opioid receptors); exhibits analgesic activity and modulates pain signaling pathways
Storage Conditions
Store at -20°C to -80°C in a dry, dark environment; avoid repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

This peptide is believed to exert its effects through interactions with opioid receptors (likely μ and/or δ subtypes), given its structural relationship to valorphin/hemorphin peptides known for opioid activity. The addition of the C-terminal arginine may influence its receptor affinity, selectivity, and metabolic stability. Upon receptor binding, it may modulate G protein-coupled signaling pathways, leading to effects such as analgesia, modulation of blood pressure, and potential influence on angiotensin-converting enzyme (ACE) activity, contributing to cardiovascular regulation.


2.PRODUCT INDICATIONS

This product is indicated for specialized research in neuropharmacology and cardiovascular physiology. Key applications include: investigating the structure-activity relationships (SAR) of hemorphin/valorphin-derived peptides and their effects on opioid receptors; studying its potential modulatory effects on blood pressure and vascular tone; exploring interactions with the renin-angiotensin system (RAS), possibly as an ACE inhibitor substrate or modifier; and serving as a tool peptide in the development of novel bioactive peptides with dual opioid and cardiovascular activities.


3.CLINICAL EFFICACY OF PRODUCT

Leu-Valorphin-Arg is a research peptide and not an approved drug. Its efficacy is defined by its role as a molecular tool in basic science. Research on such modified hemorphin analogs contributes to understanding how small peptide fragments from ubiquitous proteins like hemoglobin can regulate complex physiological systems. This knowledge could pave the way for the design of novel multitarget therapeutics that combine opioid-mediated effects  with cardiovascular benefits , although this remains in the exploratory research phase.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

High Purity Neurotensin Analogs and Exemestane Class Probes
Jul 06, 26
High Purity Neurotensin Analogs and Exemestane Class Probes
The pharmaceutical landscape is constantly evolving, with a significant focus on the development of highly specific ligands to decode complex biological systems. Within this context, the study of the exemestane class of research toolsspecifically high-purity peptide analogsplays a pivotal role in understanding receptor-mediated signaling. By utilizing precise molecular modifications, researchers can now probe the intricacies of the neurotensin system with unprecedented accuracy. Globally, the demand for specialized research probes has surged as medicinal chemistry shifts toward rational drug design. The ability to modulate binding affinity and selectivity between receptor subtypes is no longer a luxury but a necessity
Industrial Purity of Juice WATER pNA and exemestane 25 mg bodybuilding
Jul 03, 26
Industrial Purity of Juice WATER pNA and exemestane 25 mg bodybuilding
The landscape of biochemical analysis has been significantly transformed by the introduction of high-precision substrates, a field where the concept of exemestane 25 mg bodybuilding often appears in search queries despite the stark difference between clinical aromataze inhibitors and laboratory reagents. In the realm of pharmaceutical manufacturing and food science, the ability to quantify protease activity with absolute precision is paramount for maintaining product stability and quality. Understanding the mechanism of chromogenic substrates allows researchers to bridge the gap between raw biochemical data and commercial application.
Understanding the Therapeutic Role of exemestane drug class
Jul 01, 26
Understanding the Therapeutic Role of exemestane drug class
Understanding the Exemestane Drug Class and Its Therapeutic Role In the realm of endocrine therapy for breast cancer, identifying the correct exemestane drug class is critical for optimizing patient outcomes. Exemestane belongs to a specialized group of medications designed to inhibit the production of estrogen, which fuels the growth of hormone-receptor-positive breast cancers. Unlike earlier generations of hormone therapies, this class offers a more direct approach to enzymatic inhibition. By targeting the final step of estrogen synthesis, it provides a robust mechanism for managing postmenopausal oncology cases. Understanding the nuances of this pharmacological category allows researchers and clinicians to better navigate

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.